Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop.

Basic research in cardiology·2022
Same author

Clinical effects of cyclosporine in acute anterior myocardial infarction complicated by heart failure: A subgroup analysis of the CIRCUS Trial.

American heart journal·2019
Same author

The apoptotic members CD95, BclxL, and Bcl-2 cooperate to promote cell migration by inducing Ca(2+) flux from the endoplasmic reticulum to mitochondria.

Cell death and differentiation·2016
Same author

9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection.

Basic research in cardiology·2016
Same author

The SR/ER-mitochondria calcium crosstalk is regulated by GSK3β during reperfusion injury.

Cell death and differentiation·2015
Same author

The SR/ER-mitochondria calcium crosstalk is regulated by GSK3β during reperfusion injury.

Cell death and differentiation·2015

関連する実験動画

Updated: Jul 12, 2026

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
06:39

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice

Published on: April 13, 2015

冠動脈の周期的な流れの変動 "前提条件" 発血性心筋梗塞 心筋梗塞

M Ovize1, R A Kloner, S L Hale

  • 1Heart Institute Hospital of the Good Samaritan, Los Angeles, CA 90017.

Circulation
|February 1, 1992
PubMed
まとめ

自発的な冠動脈血栓形成は,心臓を予備状態にし,心臓発作の大きさを機械的予備状態に似たように減らすことができます. サイクルフロー・バリエーション (CFV) のこの保護効果は,機械的な予備条件付けとは異なり,より長いイシュケミアの後でさえも持続します.

科学分野:

  • 心血管科学 心血管科学
  • 発血性心臓病の研究について
  • 心筋膜の保護メカニズム

背景:

  • 短時間の冠動脈閉塞による機械的な予備条件付けにより,心臓発作のサイズが小さくなります.
  • 不安定性 angina のように,自発的な一時性缺血の心臓保護効果は不明です.

研究 の 目的:

  • 犬のモデルで,自発的血栓性エピソードが心臓発作のサイズを制限し,持続したイシュケミアと再注射後の収縮機能を保存するかどうかを判断する.
  • 機械的な予備条件の効果と自発的な血栓性エピソード (循環的流れ変数 - CFV) を比較する.

主な方法:

  • 犬のモデルは,60分または90分間の持続性イシュケミアを受け,その後に再注射を行った.
  • 治療群には,対照群,メカニカル・プリコンディショニング,冠動脈狭窄および内皮損傷によって誘発されたCFVが含まれていました.
  • 心臓梗塞のサイズと心筋収縮機能を評価した.

主要な成果:

  • メカニカル・プリコンディショニングとCFVの両方が,60分間のイシュケミアの後に心臓発作のサイズを著しく減少させた.
  • 結血90分後,CFVのみが対照群と比較して心臓発作のサイズを著しく減少させた.
  • どちらの予備条件付け方法も,イシュケミア/再輸液中の,またはその後の収縮機能を保たなかった.

さらに関連する動画

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

関連する実験動画

Last Updated: Jul 12, 2026

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
06:39

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice

Published on: April 13, 2015

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

結論:

  • 繰り返された冠動脈血栓形成 (CFV) は,高血圧性心筋膜を効果的に前提条件とし,機械的な前提条件よりも長く持続する保護を提供します.
  • 機械的または血栓性予備条件付けは,持続したイシュケミアの間に収縮機能を保たず,再注射後の麻痺を予防しません.
  • 不安定性アンギナの臨床的なエピソードは,潜在的に急性心筋梗塞の結果に影響を与える,心筋膜を前提にすることができます.